Biotechnology

Drug Development Gene Therapy Pharmaceuticals Vaccine Development Artificial Intelligence Aging Clinical Trials Stem Cell Research Microbial Applications Metabolic Research Cancer Diagnostics Data Privacy Human Genomics Genetic Testing Targeted Therapies Genetic Medicine Drug Discontinuation Pharmaceutical Companies Research and Development Exosomes Synthetic Biology Experimental Drugs Acellular Tissue Engineering Genomic Diagnostics Diagnostic Tools Gene Editing Gene therapies Personalized healthcare NHS data Amyotrophic Lateral Sclerosis National Security Medical Incidents Genomics Protein Engineering Vaccines Genetic Engineering Biopharmaceuticals Biodegradable Molecule AI in Drug Development Therapeutics

Engineered Extracellular Vesicles Advance Precision Therapeutic Delivery

Karolinska Institutet researchers achieve preclinical success in delivering gene editors and protein therapeutics using bioengineered vesicles.

Cue Biopharma Finalizes $20 Million Public Offering Ahead of Business Update Call

Biogen Announces Move to New Headquarters in Kendall Common

Cargo Therapeutics Ceases Operations Following Clinical and Financial Setbacks

China Adds PVH and Illumina to 'Unreliable Entity' List

Pfizer Ends Hemophilia Gene Therapy Partnership With Sangamo, Sending Stock Plummeting

Merck Secures $2 Billion Deal for Experimental Oral Weight Loss Drug from Hansoh Pharma

Roche Begins Construction on €600 Million Diagnostic Production Center in Bavaria

Breakthrough Study Reveals snoRNA's Role in Protein Secretion and Therapeutic Potential

BioNTech Acquires China's Biotheus for $800 Million to Enhance Cancer Drug Development

Synthetic Genes Pave Way for Precision-Controlled Biomolecular Materials

New Cheek Swab Test Predicts Mortality Risk

Illumina Prevails in EU Court Over Grail Merger Probe

AI Tool RENAISSANCE Revolutionizes Cell Metabolism Mapping

Briefly Bio Secures $1.2M to Tackle Science's Reproducibility Crisis

Innovative Biomaterial Transforms Menstrual Care with Gel-Forming Technology

U.S. Moves to Limit Chinese Biotech Firms Amid Security Concerns